The reaffirmation of an Outperform rating and a high price target by a reputable analyst like Jay Olson from Oppenheimer is likely to instill confidence among investors and could lead to a positive short term impact on Jasper Therapeutics' stock price. Analyst ratings, especially those with a positive outlook and high price targets, often influence investor sentiment and can lead to increased buying activity.